clinical trial · NCT06554795
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
DualityBio Inc.·phase2·recruiting·n = 360
Solid Tumor, AdultDB-1419
brief summary
A Phase 1/2a First-in-Human Study of DB-1419 in Advanced/Metastatic Solid Tumors
started
Sep 3, 2024
primary completion
Feb 1, 2027
completion
Feb 1, 2027
last updated
Mar 27, 2026
detailed description
A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1419 in Participants with Advanced/Metastatic Solid Tumors
official title
A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1419 in Participants With Advanced/Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol